News from ASCO 2021
Identifying Pre-Menopausal Patients Who Do Not Need Chemotherapy Further Confirmation of the Use of EndoPredict in Young Patients Recent data from ASCO 2021 reconfirm the…
Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing
Provides Individualized Breast Cancer Risk for Patients Testing Negative with the myRisk® Hereditary Cancer Test
Crescendo Bioscience Announces Results
Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology